Financial PR and IR for smallcap and AIM companies
London
Joined May 2009
- Tweets15.7K
- Following663
- Followers2.1K
- Likes991
✅@hargreaves_plc (AIM: #HSP) announces that they have been awarded a 15-year contract providing logistics services to the UK Deposit Return Scheme
londonstockexchange.com/en/n…
Read more below ⤵️
✅@Renalytix - US Kidney Care National Plan reinforces kidneyintelX.dkd opportunity
🚀 Marks a shift in US policy from managing kidney failure towards preventing it
➡️ Aligns directly with kidneyintelX.dkd, #RENX's FDA-authorized and Medicare-reimbursed prognostic blood test
🔑 Key themes of the Plan and their relevance:
✅ Prevention is now the stated federal priority
✅ kidneyintelX.dkd’s patient population is identified as the problem to solve
✅ Expanding early detection
✅ Implementing precision-based care
Read here: hhs.gov/press-room/hhs-launc…
➡️@VericiDx (AIM: #VRCI) welcomes the Launch of US Kidney Care National Plan
The 2026 Kidney Care National Plan centres on 3 priorities:
✅ Prevent Kidney Failure
🩸 Improve Dialysis Care and Expand Patient Choice
🚀 Reform Transplantation
Read here: hhs.gov/press-room/hhs-launc…
@FsnAntibodies plc (AIM: #FAB) - Contract Win
✅ New project covering the transient gene expression of a client’s lead antibody and a subsequent cryogenic electron microscopy study under an existing master services agreement with a global pharmaceutical company
➡️@Parsortix (AIM: #CLBX) - MSA with a Swiss biotech company
✒️Entered into MSA & a Statement of Work for a Radio-Pharmaceutical Clinical Study
✅In 2025, the market size of radioligand-therapy market had a value of ~ $3.0b, increasing to between $10.9b and $15.9b by 2035
⬆️Greater automation reduces delivery time and increases capacity,
👏The platform is currently being trialled by several customers across Chile, Singapore, the United States and the United Kingdom ahead of the planned commercial launch in December.
RNS -
londonstockexchange.com/news…
Harin Vaghela, Chief Product Officer, provides an overview of the new Invention Evaluator platform -
youtube.com/embed/cF1PR2mpbS…
➡️@edenresearch - Attendance at Annual Biocontrol Industry Meeting
👥#EDEN commercial team, including Sean Smith, CEO, and Alex Abrey, CFO, will be attending ABIM in Basel, Switzerland from 20 to 22 October 2026
🌍Leading international event for global biocontrol industry
⏩@TristelGlobal (AIM: #TSTL) - Research Summary
Cavendish view: (TP: 560.0p) Results aligned with the July trading update. Tristel closed FY26 with cash and equivalents of £16.0m, no debt and a final dividend of 9.23p.
Cavendish believe the current c3.5% dividend yield is attractive, given the expected growth and profitability of the company.
The full note is available below ⬇️
Cavendish Portal - cavendish.com/research-porta…
Research Tree - research-tree.com/providers/…